Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Menopause. 2013 Jun;20(6):631–639. doi: 10.1097/GME.0b013e31827c5c45

Table 2.

Results reported from the final models of separate logistic regression analyses examining cardio-metabolic risk in relation to experiencing any change compared to no change in menstrual cycle length.a

Any change in menstrual cycle length (n = 154) vs. No change (n = 650)
OR 95% CI p
Cardio-metabolic risk composite 1.429 1.063 – 1.920 .018
HDL 0.765 0.628 – 0.933 .008
Triglycerides 1.062 0.894 – 1.262 .495
Waist circumference 1.209 0.984 – 1.484 .071
Glucose 1.032 0.864 – 1.232 .729
Hypertension dx (1=yes, 0=no) 1.727 0.950 – 3.139 .073
a

Analyses included covariate-adjustment for age, race/ethnicity, SES, smoking, physical activity level, parity, past use of a hormonal method of birth control, and menstrual cycle length; individual cardio-metabolic risk factors (HDL, triglycerides, waist circumference, and glucose) were standardized prior to entry into the regression models.